Clinical Trial Detail

NCT ID NCT01438554
Title Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

Advanced Solid Tumor

sarcoma

cholangiocarcinoma

thyroid gland cancer

Therapies

Pazopanib + Trametinib

Age Groups: adult senior

No variant requirements are available.